Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The company generates revenue through the sale of its proprietary medications, which include treatments for epilepsy, migraine, and Parkinson's disease, among others. Founded in 2005, Supernus has a history of leveraging its expertise in drug formulation and development to bring innovative therapies to market. The company is committed to addressing unmet medical needs and improving the lives of patients with CNS disorders through its robust pipeline of product candidates and strategic acquisitions.

Recent Posts by Supernus Pharmaceuticals

1-20 of 27